{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-039261","form_type":"8-K","ticker":"ESLA","cik":"0001844417","company_name":"Estrella Immunopharma, Inc.","filed_at":"2025-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.102098+00:00","generated_at":"2026-05-22T23:05:42.828833+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Estrella Immunopharma receives Nasdaq bid price deficiency notice; faces potential delisting","bullets":["Nasdaq notified Estrella that common stock failed to maintain $1.00 minimum bid for 30 consecutive days through April 28, 2025.","Company has 180-day compliance period (until October 27, 2025) to regain compliance with Bid Price Rule.","If not compliant by October 27, may seek additional 180-day period if it meets other listing standards.","No immediate effect on listing; common stock and warrants continue trading on Nasdaq under ESLA and ESLAW."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-039261","json":"https://secwatch.observer/filing/0001213900-25-039261.json","markdown":"https://secwatch.observer/filing/0001213900-25-039261.md","text":"https://secwatch.observer/filing/0001213900-25-039261.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844417/000121390025039261/0001213900-25-039261-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844417/000121390025039261/ea0240454-8k_estrella.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T23:05:42.828833+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}